Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion

Wei Li1, Qin Yin1, Gelin Xu1

  • 1Department of Neurology, Jinling Hospital, Southern Medical University, Nanjing, China.

Interventional Neurology
|October 27, 2016
PubMed

Insights

Acute ischemic stroke from internal carotid artery occlusion has poor outcomes. Endovascular recanalization is a potential treatment, but diverse causes challenge neurointerventionists, necessitating further research.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Interventional Neurology

Background:

  • Acute ischemic stroke due to internal carotid artery (ICA) occlusion often leads to poor prognosis, particularly in cases lacking collateral circulation.
  • The effectiveness of intravenous (IV) or intra-arterial (IA) thrombolysis using recombinant tissue plasminogen activator (rt-PA) is uncertain for these patients.
  • Endovascular recanalization has emerged as a potential therapeutic strategy for acute ICA occlusion.

Approach:

  • This review synthesizes current treatment modalities for acute ICA occlusion.
  • It examines the challenges posed by the varied etiologies of ICA occlusion in neurointervention.
  • Recent advancements in endovascular techniques for carotid occlusion-related stroke are discussed.

Key Points:

  • Internal carotid artery occlusion presents a significant challenge in acute ischemic stroke management.
  • Recombinant tissue plasminogen activator (rt-PA) efficacy is debated in these specific cases.
  • Endovascular approaches are increasingly explored as a viable treatment option.

Conclusions:

  • The review highlights the evolving landscape of endovascular treatments for acute ICA occlusion.
  • Understanding diverse etiologies is crucial for successful neurointervention.
  • Further research is needed to optimize treatment strategies and improve patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
358
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
373
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
428